Journal Publication

PVA microsphere rhinoplasty holds shape in 30 Asia female patients over 24 months

A single-arm case series links a surgical-like PVA microsphere injection technique to sustained nasal aesthetic gains and low regression, without a comparator arm.

By AppliedXLJuly 13, 2026

Executive Summary

A case series testing an injectable filler technique for nasal augmentation reported improvement across every quantitative aesthetic measure it tracked, with no structural widening over extended follow-up.
The study enrolled a small, single-arm cohort followed for over a year and a half, which can establish a within-patient change but cannot establish how the technique performs against an alternative filler or against surgery.
The only adverse events reported were transient and mild, consistent with a favorable tolerability picture for the injection technique in this cohort.
The result adds a technique-level data point to nasal augmentation practice, showing that a specific injection method combined with this filler material can sustain shape without the widening associated with conventional hyaluronic acid injection in this cohort.

The stake

Surgical rhinoplasty carries a long recovery and a documented tendency toward revision surgery, and conventional hyaluronic acid (HA, a common injectable filler) filler is prone to nasal widening over time, the study notes. The technique tested here combines PVA microspheres, a longer-lasting synthetic filler, with an injection method described as surgical-like: membranous septum injection for tip projection and dorsal injection for height, aimed at Asia female patients whose nasal skeletal anatomy drives demand for augmentation. PVA

How it was done

The study enrolled 30 Asia female patients in a single-arm design with no control group, following each patient for 18 to 24 months after injection. Primary outcomes were four quantitative aesthetic indices, nostril-to-nasal-base ratio, nasolabial angle, nasofrontal angle, and nasal root height difference, plus morphology maintenance measured as absence of widening and a regression rate. Secondary outcomes were patient-reported satisfaction on a 10-point visual analog scale and a ROE (rhinoplasty outcome evaluation) questionnaire, alongside adverse event tracking. PVA

The results

All four indices moved from baseline with statistical significance (P<0.001): the nostril/nasal-base ratio rose from 0.42 to 0.58, the nasolabial angle widened from 85.3 to 95.6 degrees, the nasofrontal angle narrowed from 135.2 to 120.5 degrees, and nasal root height difference increased from 2.1 mm to 3.5 mm. No patient developed nasal widening, and the 24-month regression rate was 8.3%. PVA

Satisfaction and safety

Mean patient satisfaction scored 8.9 out of 10 on the VAS, and the ROE questionnaire score rose from 58.3 to 89.6 (P<0.001). Three patients had transient erythema (temporary redness), and no severe adverse events were reported across the cohort. The pairing of sustained morphology, low regression, and high reported satisfaction reinforces the study's own premise: the surgical-like injection placement, not the filler material alone, may be what limits the widening seen with conventional HA injection. PVA

This analysis was produced using AI-assisted reporting systems, AppliedXL data, and official public records. These systems undergo editorial review, quality checks, and regular audits by human experts. Errors may still occur, as with any automated system. Always consult the linked primary sources. Read our AI Editorial Policy.